Alnylam Pharmaceuticals (NASDAQ:ALNY) Upgraded to Strong-Buy at Wall Street Zen
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a report issued on Saturday. A number of other analysts have also recently issued reports on the company. Barclays lifted their price objective on Alnylam Pharmaceuticals from $329.00 to $460.00 […]
More Stories
California-Based Family Members of Qasem Soleimani Arrested, Green Cards Revoked
By Jacki Thrapp Two family members of assassinated Islamic Revolutionary Guard Corps Major General Qasem Soleimani were arrested by federal...
‘WE GOT HIM!’: Trump Says US Forces Rescue 2nd Airman Downed in Iran
By Ryan Morgan U.S. forces have successfully rescued a second U.S. airman whose F-15 Strike Eagle fighter jet was shot...
Monthly Payments for Homes Increased 1st Time in 6 Months
By Naveen Athrappully The median monthly mortgage payment in the United States hit $2,742 for the four weeks ending March...
Trump’s 3D Chess: How President Trump Is Checkmating China and Russia by Toppling Their Oil Proxies in Venezuela, Cuba, and Iran
By Stephen Zogopoulos, USNN World News In the rarefied world of grand strategy, true masters don’t play on a flat...
Iran Vows Lasting Grip on Strait of Hormuz After War
By Tom Ozimek Iran has signaled that it intends to exert lasting control over the Strait of Hormuz—the world’s most...
Trump Signs Memo to Pay All DHS Employees During Shutdown
By Troy Myers President Donald Trump on Friday signed a memorandum directing the Department of Homeland Security (DHS) to pay...